McLean Signature Recovery Programs: Fernside

ADD YOUR REVIEW
162 Mountain Road
Princeton, MA 01541
8446710141 Visit Website

Paying for Treatment

  • Insurance is not Accepted
  • Financing is not Available
  • Medicare is not Accepted
  • Medicaid is not Accepted

Treatment Insights

Harvard Medical School-affiliated McLean Fernside specializes in residential treatment plans that address the primary addiction as well as accompanying co-occurring psychiatric disorders. As part of our Signature Recovery Programs, McLean Fernside is a self-pay residential program providing unparalleled treatment in an unsurpassed setting. Our clinicians are experts in substance abuse recovery, rehabilitation and relapse prevention. They help to motivate individuals in their care to take the necessary steps to overcome addiction.

McLean Signature Recovery Programs: Fernside Reviews and Ratings Details

The following is based on a combination of Surveys of Alumni, Staff, Loved Ones, and Reviews and Ratings from around the web.

Reviews at a Glance


Areas of Focus
Individualized Treatment

Some facilities have an addiction treatment protocol that all patients or clients are expected to follow, while others customize or individualize treatment based on a person’s unique needs and circumstances. Factors that may affect treatment decisions include age, lifestyle, medical conditions, type of drug, religious beliefs, etc.

Cognitive Behavioral Therapy (CBT)

The focus of cognitive behavioral therapy (also called CBT) is helping people to understand the thoughts and emotions that underlie their addiction with the goal of learning new, healthier and more productive ways to understand and express themselves.

Key Staff Members
  • Photo of
    Rocco A. Iannucci, MD - Medical Director, Fernside, Instructor in Psychiatry, Harvard Medical School

    Board certified in psychiatry and addiction psychiatry by the American Board of Psychiatry and Neurology, Dr. Iannucci is an instructor in psychiatry at Harvard Medical School. His clinical interests include treatment of people with severe substance use disorders and those with co-occurring mental health conditions. He has published on the treatment of addiction in residential programs, and on cocaine abuse.

  • Photo of
    Roger D. Weiss, MD - Chief, Division of Alcohol and Drug Abuse; Director, Alcohol and Drug Abuse Clinical Research Program, Professor of Psychiatry, Harvard Medical School

    Dr. Weiss’ career has focused on treatment and clinical research with substance-dependent patients. He has received numerous NIH grants, developing integrated group therapy, an evidence-based treatment for co-occurring bipolar and substance use disorders, and leading a multi-site treatment study of prescription opioid dependence. He has authored over 300 publications, including several books, and was vice chair of the American Psychiatric Association Task Force on Practice Guidelines for Patients with Substance Use Disorders.